Mylan And Lupin Prepare To Launch EU Etanercept

Formal European Commission Approval Received For Nepexto Version

Mylan and Lupin have revealed when they expect to launch their etanercept biosimilar, Nepexto, in Europe after receiving formal European Commission approval.

Euro_Rocket
Mylan and Lupin are hoping to capitalize on the European etanercept opportunity with their launch • Source: Shutterstock

More from Biosimilars

More from Products